Clinical Trial Update: Efficacy and Safety Study of Nasalfent for Treatment of Breakthrough Cancer Pain in Patients Taking Regular Opioids [Phase 3]

View source ↗

Summary

This document reports the completion of a Phase 3 trial evaluating Nasalfent for breakthrough cancer pain in patients on regular opioids. It summarizes the tria…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cancer

Drugs mentioned

• Nasalfent (fentanyl)

Snippet

Sponsor: Archimedes Development Ltd | Conditions: Cancers, Pain | Phase 3 | Status: COMPLETED